AssuntinaGSaccoMD

Head & Neck Cancer, Hematologic Oncology

Associate Professor of Internal Medicine, Division of Hematology-Oncology Infusion Center Medical Director, Moores Cancer Center

Dr. Sacco is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3855 Health Sciences Drive
#0658
La Jolla, CA 92093
Phone+1 858-822-5800

Fax+1 858-822-5754

PubMed

1 citations
Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label,...
Loren K Mell, Pedro A Torres-Saavedra, Stuart J Wong, Julie A Kish, Steven S Chang
The Lancet. Oncology. 2024-12-01
Sister partnership to overcome the global burden of cancer.
Nicolas Magné, Sandrine Sotton, Ana Varges Gomes, Gustavo Nader Marta, Raúl Eduardo Giglio
The British Journal of Radiology. 2024-12-01
Redefining Candidates for Deintensification in Locoregionally Advanced P16+ Oropharyngeal Cancer Based on Relative Risk.
Ryan T Morse, Tyler J Nelson, Hannah C Liu, Prangrawee Sangchan, Bhargava Chitti
International Journal of Radiation Oncology, Biology, Physics. 2024-09-21

Lectures

An open label, nonrandomized, multi-arm, phase II trial evaluating pembrolizumab combined with cetuximab in patients with recurrent/metastatic (R/M) head and neck squa...
ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019